723 related articles for article (PubMed ID: 12412178)
1. Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma.
Cerchietti LC; Navigante AH; Bonomi MR; Zaderajko MA; Menéndez PR; Pogany CE; Roth BM
Cancer; 2002 Nov; 95(10):2230-6. PubMed ID: 12412178
[TBL] [Abstract][Full Text] [Related]
2. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
[TBL] [Abstract][Full Text] [Related]
3. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
[TBL] [Abstract][Full Text] [Related]
4. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
Yen SH; Wang LW; Lin YH; Jen YM; Chung YL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1463-70. PubMed ID: 21840136
[TBL] [Abstract][Full Text] [Related]
5. Honey as topical prophylaxis against radiochemotherapy-induced mucositis in head and neck cancer.
Rashad UM; Al-Gezawy SM; El-Gezawy E; Azzaz AN
J Laryngol Otol; 2009 Feb; 123(2):223-8. PubMed ID: 18485252
[TBL] [Abstract][Full Text] [Related]
6. Palifermin for oral mucositis after intensive therapy for hematologic cancers.
Spielberger R; Stiff P; Bensinger W; Gentile T; Weisdorf D; Kewalramani T; Shea T; Yanovich S; Hansen K; Noga S; McCarty J; LeMaistre CF; Sung EC; Blazar BR; Elhardt D; Chen MG; Emmanouilides C
N Engl J Med; 2004 Dec; 351(25):2590-8. PubMed ID: 15602019
[TBL] [Abstract][Full Text] [Related]
7. Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life.
Elting LS; Keefe DM; Sonis ST; Garden AS; Spijkervet FK; Barasch A; Tishler RB; Canty TP; Kudrimoti MK; Vera-Llonch M;
Cancer; 2008 Nov; 113(10):2704-13. PubMed ID: 18973181
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire.
Epstein JB; Beaumont JL; Gwede CK; Murphy B; Garden AS; Meredith R; Le QT; Brizel D; Isitt J; Cella D
Cancer; 2007 May; 109(9):1914-22. PubMed ID: 17377917
[TBL] [Abstract][Full Text] [Related]
9. Relationship between clinical factors and the incidence of toxicity after intra-arterial chemoradiation for head and neck cancer.
van den Broek GB; Balm AJ; van den Brekel MW; Hauptmann M; Schornagel JH; Rasch CR
Radiother Oncol; 2006 Nov; 81(2):143-50. PubMed ID: 17055096
[TBL] [Abstract][Full Text] [Related]
10. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
[TBL] [Abstract][Full Text] [Related]
11. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.
Veness MJ; Foroudi F; Gebski V; Timms I; Sathiyaseelan Y; Cakir B; Tiver KW
Australas Radiol; 2006 Oct; 50(5):468-74. PubMed ID: 16981945
[TBL] [Abstract][Full Text] [Related]
12. Effect of Doxepin Mouthwash or Diphenhydramine-Lidocaine-Antacid Mouthwash vs Placebo on Radiotherapy-Related Oral Mucositis Pain: The Alliance A221304 Randomized Clinical Trial.
Sio TT; Le-Rademacher JG; Leenstra JL; Loprinzi CL; Rine G; Curtis A; Singh AK; Martenson JA; Novotny PJ; Tan AD; Qin R; Ko SJ; Reiter PL; Miller RC
JAMA; 2019 Apr; 321(15):1481-1490. PubMed ID: 30990550
[TBL] [Abstract][Full Text] [Related]
13. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic analysis and phase 1 study of MRX-1024 in patients treated with radiation therapy with or without cisplatinum for head and neck cancer.
Hamstra DA; Eisbruch A; Naidu MU; Ramana GV; Sunkara P; Campbell KC; Ross BD; Rehemtulla A
Clin Cancer Res; 2010 May; 16(9):2666-76. PubMed ID: 20388849
[TBL] [Abstract][Full Text] [Related]
15. [Management of oral mucositis in patients with head and neck cancer receiving chemoradiotherapy and/or molecular targeted therapy].
Zhang XX; Ma L; Wang JL; Wu WM; Feng LC; Huang DL
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jun; 46(6):505-8. PubMed ID: 21924104
[TBL] [Abstract][Full Text] [Related]
16. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
[TBL] [Abstract][Full Text] [Related]
17. Double-blinded, placebo-controlled trial on intravenous L-alanyl-L-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer.
Cerchietti LC; Navigante AH; Lutteral MA; Castro MA; Kirchuk R; Bonomi M; Cabalar ME; Roth B; Negretti G; Sheinker B; Uchima P
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1330-7. PubMed ID: 16765532
[TBL] [Abstract][Full Text] [Related]
18. Mucositis-related morbidity and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapy.
Murphy BA; Beaumont JL; Isitt J; Garden AS; Gwede CK; Trotti AM; Meredith RF; Epstein JB; Le QT; Brizel DM; Bellm LA; Wells N; Cella D
J Pain Symptom Manage; 2009 Oct; 38(4):522-32. PubMed ID: 19608377
[TBL] [Abstract][Full Text] [Related]
19. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies.
Elting LS; Cooksley CD; Chambers MS; Garden AS
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1110-20. PubMed ID: 17398022
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
Brizel DM; Murphy BA; Rosenthal DI; Pandya KJ; Glück S; Brizel HE; Meredith RF; Berger D; Chen MG; Mendenhall W
J Clin Oncol; 2008 May; 26(15):2489-96. PubMed ID: 18487568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
